Gerresheimer extends production of medical plastic systems in Bavaria

• Growth in demand for pharmaceutical and medical plastic systems
• Gerresheimer invests around EUR 25 million in its Pfreimd plant
• 130 new jobs

Düsseldorf, December 19, 2011. Gerresheimer AG, one of the world's leading suppliers to the pharma and healthcare industry, further invests in the growth market of complex plastic systems for pharmaceutical and medical applications. Production capacity is being extended at the southern German production facility in Pfreimd at the value of approximately EUR 25 million. High customer demand led to the decision to among other investment to construct a new production hall where medical plastic systems will be manufactured in clean room environments with state-of-the-art injection moulding machines. As a result of this project around 130 new jobs will be created in Pfreimd.

“There has been a sharp increase in demand for medical delivery systems which are simple and safe for patients to use. These include injection systems, insulin pens and inhalers. We are increasing our production capacity so that we can drive future growth in this market,” commented Uwe Röhrhoff, CEO of Gerresheimer AG.

The Plastic Systems division is now one of the company’s fastest-growing divisions. Gerresheimer Medical Plastic Systems produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and disposable laboratory articles for leading pharma and medical technology companies – from the initial design sketches, through tool making and production to packaging and just-in-time delivery.

Inhalers, diabetic supplies such as insulin pens, lancing devices, lancets and disposable laboratory articles are some of the products manufactured in Pfreimd. The plant currently has 550 employees.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia.  We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Contact
Jens Kuerten
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-Mail: please click